A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
about
Sublingual immunotherapy for asthmaAllergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®.A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitisMagnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposureThe efficacy assessment of a self-administered immunotherapy protocolA comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis.Selection of patients for sublingual versus subcutaneous immunotherapy.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment.A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Comparison of six disease severity scores for allergic rhinitis against pollen counts a prospective analysis at population and individual level.Investigation of possible risk factors in the development of seasonal allergic conjunctivitis
P2860
Q24187736-AC0CC02B-D752-406C-8AEC-B018996F8C70Q31051777-CE93D3F9-D9BB-414A-8475-10B4433174F5Q33914193-CABCDA98-2A20-47C7-830A-4FB66B40CA6AQ35040990-3DE0F7AE-49F8-4E3F-84DF-281CD3C30A28Q36881918-24BBCB17-988D-464C-AE7F-0AC8252D845FQ38207691-121014F8-81C4-47B9-8568-47001E718BCFQ38257644-B21E8E03-42F9-43A6-B603-44060A298E68Q38262168-5181C0B3-BCD1-4296-8F2E-49F77AF7EE37Q38271427-34057CF5-3BFB-444E-B825-157ECAFAE31AQ38286266-0ABBDCC5-3E37-4B31-83ED-6D993C2A8357Q38476590-54B896A9-0FBE-48F2-9F7D-1C3D79C043D7Q38888019-42A0E313-5971-4A98-A2FB-404B477055E2Q39908406-E52AF5B0-C366-4F9D-B2F6-159811FE9A73Q58728173-082C3A0B-C4AD-405D-A141-83EEFED0819D
P2860
A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A phase 3 trial assessing the ...... vitis, with or without asthma.
@en
type
label
A phase 3 trial assessing the ...... vitis, with or without asthma.
@en
prefLabel
A phase 3 trial assessing the ...... vitis, with or without asthma.
@en
P2093
P2860
P921
P356
P1476
A phase 3 trial assessing the ...... vitis, with or without asthma.
@en
P2093
David Bernstein
Jens Andersen
Kevin Murphy
Martin Rud Pedersen
Sandra Gawchik
P2860
P356
10.1186/1477-5751-12-10
P577
2013-06-01T00:00:00Z